Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folinic Acid Rescue in Pemetrexed-Treated NSCLC/Mesothelioma
NCT06010277Phase 4Unknown
- Sponsor
- Amphia Ziekenhuis
- Start
- Feb 2023
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of folinic acid in neutropenia, sponsored by Amphia Ziekenhuis. Status: unknown.
02
Drugs
folinic acid
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT06010277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06010277.